Joanna Brewer was appointed Chief Scientific Officer at Adaptimmune, according to the company’s press release.
Joanna Brewer was appointed Chief Scientific Officer at Adaptimmune, according to the company’s press release. Public sources provided here do not identify her earlier career history or confirm that she is a founder of TCR2, so additional biographical details are not supported by the available evidence. Adaptimmune describes the appointment in the context of its cell therapy and TCR-based immuno-oncology work.
Full founder directory · Investor directory · Company funding database · Fundraising library